Medical Cannabis Advocacy in Mexico During the 1950s

Setting the scene: what Mexico inherited going into 1950

To understand the 1950s, you have to understand what came before. Mexico prohibited the sale and recreational use of cannabis in 1920 through a federal sanitary decree, seven years before the United States federally restricted it ^[1]. Cultivation was banned in 1927. By 1940, Dr. Leopoldo Salazar Viniegra — head of the federal narcotics service — pushed through the Reglamento Federal de Toxicomanías, which briefly treated addiction as a public health matter and allowed state-run dispensaries for addicts ^[2][3]. That reform lasted less than six months before U.S. pressure and domestic opposition forced its suspension in July 1940 ^[2].

So by January 1950, Mexico had already tried, and lost, its most ambitious medical-model drug reform of the twentieth century. The reformist wing associated with Salazar Viniegra had been sidelined. What remained was an enforcement regime.

What actually happened in the 1950s

The 1950s in Mexican drug policy are best described as a decade of consolidation of prohibition, not reform. Key developments:

• Enforcement expansion. The Procuraduría General de la República expanded its narcotics division. Cannabis eradication campaigns in Sinaloa, Durango, and Guerrero intensified, often in coordination with U.S. Federal Bureau of Narcotics agents ^[4].
• International alignment. Mexico participated in the 1953 Opium Protocol negotiations and moved toward the framework that would become the 1961 Single Convention on Narcotic Drugs, which classified cannabis as a Schedule IV substance with no recognized medical use ^[5].
• Medical literature: sparse. A search of Mexican medical journals from the period (Gaceta Médica de México, Revista Médica del IMSS founded 1961) shows very few clinical articles on cannabis in this decade. What appears tends to frame cannabis as a cause of psychosis or delinquency, echoing earlier framings by physicians like Francisco Castañeda in the 1880s ^[6].

There was no organized 1950s Mexican patient-advocacy movement analogous to what emerged in the United States in the 1970s (NORML, 1970) or Mexico's own post-2015 amparo litigation wave. Strong evidence

Why the myth of 1950s Mexican medical advocacy persists

Several things get compressed in popular retellings:

1. Salazar Viniegra's 1938–1940 reform is sometimes misdated to the 1950s because it was written about retrospectively in that decade. His work is real and important — just earlier ^[2][3].
2. Traditional and folk medical use of cannabis (called Santa Rosa or la Santa María in some Indigenous and rural syncretic practices in central and western Mexico) continued through the 1950s, but this is a matter of curanderismo and folk practice, not organized medical advocacy ^[7]. Weak / limited
3. Isaac Campos's historical work Home Grown (2012) showed that Mexico's anti-cannabis discourse was largely homegrown and predated U.S. pressure — which sometimes gets flipped in popular retellings into a claim that Mexico had a pro-cannabis medical tradition suppressed by the U.S. That is not what Campos argues ^[1].

Calling the 1950s a period of Mexican medical cannabis advocacy is, in short, folklore. Disputed

Figures sometimes associated with the era

• Leopoldo Salazar Viniegra (1898–1957): The most important reformist voice, but his active policy years were the late 1930s. He lived through the 1950s and died in 1957, but published little on cannabis reform in his final years ^[2].
• Fernando Rosenzweig and mid-century public health officials: Focused on tuberculosis, polio, and maternal health — not cannabis reform.
• U.S.-side counterparts: Harry Anslinger of the FBN continued to shape Mexican policy from the outside through diplomatic pressure throughout the 1950s ^[4].

If a source tells you about a specific 1950s Mexican doctor leading a medical cannabis campaign, ask for the primary citation. In our research we could not locate one.

What came after: why the story picks up again

Mexican medical cannabis advocacy in any organized sense really begins in the 2010s, driven by:

• The 2015 Supreme Court (SCJN) Grace case, granting an amparo for personal cultivation on autonomy grounds ^[8].
• The 2017 reform to the Ley General de Salud permitting medical cannabis products with under 1% THC ^[9].
• Subsequent SCJN rulings declaring absolute prohibition of adult personal use unconstitutional (2018–2021) ^[8].

The through-line from Salazar Viniegra's 1940 reform to the 2015 amparo skips the 1950s almost entirely. That is the honest historical picture.

Sources

How this page was made